首页539523 • BOM
add
Alkem Laboratories Ltd
昨日收盘价
₹4,723.95
当日价格范围
₹4,609.50 - ₹4,752.90
年度波幅
₹4,409.90 - ₹6,440.00
市值
5534.54亿 INR
平均交易量
3588.00
市盈率
25.73
股息率
0.91%
主要交易所
NSE
相关资讯
财务信息
损益表
收入
净收入
(INR) | 2024年12月info | 年同比变化 |
---|---|---|
收入 | 337.43亿 | 1.52% |
经营支出 | 149.58亿 | 8.29% |
净收入 | 62.58亿 | 5.19% |
净利润率 | 18.55 | 3.63% |
每股收益 | 52.34 | -2.59% |
息税折旧摊销前利润 | 73.89亿 | 4.74% |
有效税率 | 12.35% | — |
资产负债表
总资产
负债总额
(INR) | 2024年12月info | 年同比变化 |
---|---|---|
现金及短期投资 | 228.89亿 | -36.59% |
总资产 | — | — |
负债总额 | — | — |
权益总额 | 1191.01亿 | — |
发行在外的股份 | 1.20亿 | — |
市净率 | 4.91 | — |
资产回报率 | — | — |
资本回报率 | 12.59% | — |
现金流
现金净变动
(INR) | 2024年12月info | 年同比变化 |
---|---|---|
净收入 | 62.58亿 | 5.19% |
来自运营的现金 | — | — |
投资现金 | — | — |
融资现金 | — | — |
现金净变动 | — | — |
自由现金流 | — | — |
简介
Alkem Laboratories Limited is a leading Indian multinational pharmaceutical company headquartered in Mumbai, India. Specialising in generics and speciality pharmaceuticals, Alkem manufactures and markets a diverse portfolio of pharmaceutical generics, formulations and nutraceuticals across India and global markets.
With over five decades of expertise in the pharmaceutical industry, Alkem's journey began with a vision to transform India's healthcare landscape. Today, the company has established its presence in over 40 countries, operating 19 state-of-the-art manufacturing facilities and driving innovation through a team of 500+ scientists. Backed by a robust portfolio of 800+ brands, Alkem continues to set industry benchmarks in research, development, and manufacturing excellence.
Alkem primarily focuses on developing medications for a wide range of therapeutic areas, including infectious diseases, gastrointestinal disorders, pain management, gynecological conditions, pediatrics, osteoporosis, arthritis, cardiovascular diseases, diabetes, and several other critical health concerns. Wikipedia
成立时间
1973
员工数量
17,432